3-(2-Bromo-4,5-dimethoxyphenyl)propionitrile

Hengkang Pharmaceutical was established in 2004, is specialized in active pharmaceutical ingredients development, GMP manufacturing and marketing，and provides the most innovative intermediates and APIs to world-wide customers. Nucleic Acid Division is lead by PhD team with rich pharmaceutical industry background, focusing on the independent research and development of key raw materials and excipients of mRNA drugs and oligos, such as Cap Analog and intermediate, Nucleotide, modified Nucleotide, Enzyme, Cationic acid(Ionizable Lipid), phosphoramidite, and commercial production base with GMP system. Dedicated to become the best partner of innovative nucleic acid drug field. The company has more than 6,000 square meters of R & D laboratories, more than 60,000 square meters of commercial GMP production base, first-class inspection instruments and production equipment; has a stable and experienced R & D team, as well as a perfect GMP production system, assists domestic and foreign mRNA R & D enterprises and manufacturers, and provides key raw materials and CMC solutions with controllable costs.? Can provide nucleotides and modified nucleotides, the product quality has reached the international level, and the cost is controllable, and the batch-to-batch quality is stable; Can provide capping materials for mRNA synthesis to achieve efficient and economical co-transcription capping; Can provide LNP raw materials that meet the requirements of the nucleic acid delivery system and meet the GMP production conditions; Can provide mRNA engineering enzymes and adopt absolute quantitative detection methods to ensure that key quality indicators such as enzyme bioactivity and residues are effectively controlled.